Cargando…

Aspergillus infection in chronic obstructive pulmonary diseases

Chronic obstructive pulmonary disease (COPD) is a chronic airway non‐specific inflammatory disease characterised by airway obstruction and alveolar destruction. In recent years, due to the extensive use of antibiotics, glucocorticoids, immunosuppressants and other drugs, pulmonary fungal infection i...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Liang, Wu, Xiulin, Wu, Xueling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978918/
https://www.ncbi.nlm.nih.gov/pubmed/36710403
http://dx.doi.org/10.1111/crj.13585
_version_ 1784899626678091776
author Guo, Liang
Wu, Xiulin
Wu, Xueling
author_facet Guo, Liang
Wu, Xiulin
Wu, Xueling
author_sort Guo, Liang
collection PubMed
description Chronic obstructive pulmonary disease (COPD) is a chronic airway non‐specific inflammatory disease characterised by airway obstruction and alveolar destruction. In recent years, due to the extensive use of antibiotics, glucocorticoids, immunosuppressants and other drugs, pulmonary fungal infection in patients with AECOPD, especially aspergillus infection, has gradually increased. The forms of aspergillus infection present in COPD patients include sensitisation, chronic pulmonary aspergillosis (CPA) and invasive pulmonary aspergillosis (IPA). This review will summarise diagnostic and treatment of aspergillus in COPD patients.
format Online
Article
Text
id pubmed-9978918
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99789182023-03-03 Aspergillus infection in chronic obstructive pulmonary diseases Guo, Liang Wu, Xiulin Wu, Xueling Clin Respir J Review Articles Chronic obstructive pulmonary disease (COPD) is a chronic airway non‐specific inflammatory disease characterised by airway obstruction and alveolar destruction. In recent years, due to the extensive use of antibiotics, glucocorticoids, immunosuppressants and other drugs, pulmonary fungal infection in patients with AECOPD, especially aspergillus infection, has gradually increased. The forms of aspergillus infection present in COPD patients include sensitisation, chronic pulmonary aspergillosis (CPA) and invasive pulmonary aspergillosis (IPA). This review will summarise diagnostic and treatment of aspergillus in COPD patients. John Wiley and Sons Inc. 2023-01-29 /pmc/articles/PMC9978918/ /pubmed/36710403 http://dx.doi.org/10.1111/crj.13585 Text en © 2023 The Authors. The Clinical Respiratory Journal published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Articles
Guo, Liang
Wu, Xiulin
Wu, Xueling
Aspergillus infection in chronic obstructive pulmonary diseases
title Aspergillus infection in chronic obstructive pulmonary diseases
title_full Aspergillus infection in chronic obstructive pulmonary diseases
title_fullStr Aspergillus infection in chronic obstructive pulmonary diseases
title_full_unstemmed Aspergillus infection in chronic obstructive pulmonary diseases
title_short Aspergillus infection in chronic obstructive pulmonary diseases
title_sort aspergillus infection in chronic obstructive pulmonary diseases
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978918/
https://www.ncbi.nlm.nih.gov/pubmed/36710403
http://dx.doi.org/10.1111/crj.13585
work_keys_str_mv AT guoliang aspergillusinfectioninchronicobstructivepulmonarydiseases
AT wuxiulin aspergillusinfectioninchronicobstructivepulmonarydiseases
AT wuxueling aspergillusinfectioninchronicobstructivepulmonarydiseases